Walleye Capital
HAE icon

Walleye Capital’s Haemonetics HAE Stock Holding History

Walleye Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,000
Closed -$240K – 4639
2025
Q4 		$240K Buy
+3,000
New +$202K ﹤0.01% 3437
2025
Q2 		– Sell
-2,500
Closed -$159K – 4701
2025
Q1 		$159K Sell
2,500
-900
-26% -$61.2K ﹤0.01% 3408
2024
Q4 		$265K Sell
3,400
-1,900
-36% -$153K ﹤0.01% 3532
2024
Q3 		$426K Buy
+5,300
New +$428K ﹤0.01% 3442
2019
Q2 		– Sell
-3,900
Closed -$341K – 1854
2019
Q1 		$341K Buy
+3,900
New +$355K 0.06% 544

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Walleye Capital's HAE Position: Q1 2026 in Review

Walleye Capital increased its Haemonetics (HAE) stake by 11% in Q1 2026, buying an estimated $418K and bringing the position to 66,359 shares worth $3.74M. The position accounts for 0.02% of the portfolio, ranked #994.

Walleye Capital first reported a position in HAE in Q1 2019 and has held it in 13 quarters since. The position peaked at $14.7M in Q2 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Walleye Capital held 66,359 shares of Haemonetics worth $3.74M as of Q1 2026.
  • Walleye Capital bought 6,411 Haemonetics shares in Q1 2026, an estimated $418K.
  • Haemonetics made up 0.02% of Walleye Capital's portfolio in Q1 2026, its #994 holding.
  • Walleye Capital first reported a position in Haemonetics in Q1 2019 and has held it in 13 quarters since.
  • Walleye Capital's Haemonetics position peaked at $14.7M in Q2 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.